Bulk Manufacturer of Controlled Substances Application: AMRI Rensselaer, Inc., 95639-95640 [2016-31284]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices
Albuquerque, New Mexico.
Goff, F., and Goff, C.J., In Press (2016–17),
Overview of the Valles Caldera (Baca)
geothermal system, New Mexico, in
(McLemore, V.T. and Timmons, S., eds.)
Energy and Mineral Resources of New
Mexico. New Mexico Bureau of Geology
and Mineral Resources, Special
Publication 13, 50 pages, with 5 tables,
1 appendix, and 40 figures.
Goff, F. (2002). ‘‘Geothermal Potential of
Valles Caldera, New Mexico.’’ GHC
Bulletin, December 2002.
Goff, F. and Grigsby, C. (1982). Valles Caldera
Geothermal Systems, New Mexico, USA.
Journal of Hydrology, 56 (1982) pp. 119–
136.
Geologic Map of the Jemez mountains, Valles
Caldera (2011). https://geoinfo.nmt.edu/
repository/data/2011/20110002/GM-79_
mapsheet.pdf. https://en.openei.org/wiki/
Valles_Caldera--Sulphur_Springs_
Geothermal_Area/#Regional Setting.
Trainer, F.W.; Rogers, R.J., and M.L. Sorey,
2000. ‘‘Geothermal Hydrology of Valles
Caldera and the Southwestern Jemez
Mountains, New Mexico.’’ U.S.
Geological Survey, Water Resources
Investigation report 00–4067, 115 pp.
www.hotspringsenthusiast.com/
newmexico.asp.
Dated: December 19, 2016.
Michael Bean,
Principal Deputy Assistant Secretary, Fish
and Wildlife and Parks.
[FR Doc. 2016–31270 Filed 12–27–16; 8:45 am]
By order of the Commission.
Issued: December 22, 2016.
Lisa R. Barton,
Secretary to the Commission.
BILLING CODE 4312–52–P
INTERNATIONAL TRADE
COMMISSION
BILLING CODE 7020–02–P
JUDICIAL CONFERENCE OF THE
UNITED STATES
Iron Construction Castings From
Brazil, Canada, and China
Hearings of the Judicial Conference
Advisory Committee on the Federal
Rules of Appellate Procedure
Determination
On the basis of the record 1 developed
in the subject five-year reviews, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that revocation of the
countervailing duty order on heavy iron
construction castings from Brazil, the
antidumping duty order on heavy iron
construction castings from Canada, and
the antidumping duty orders on iron
construction castings from Brazil and
China would be likely to lead to
continuation or recurrence of material
injury to industries in the United States
within a reasonably foreseeable time.
Advisory Committee on the
Federal Rules of Appellate Procedure,
Judicial Conference of the United States.
ACTION: Notice of cancellation of public
hearing.
AGENCY:
The following public hearing
on proposed amendments to the Federal
Rules of Appellate Procedure has been
canceled: Appellate Rules Hearing on
January 20, 2017, in Denver, Colorado.
Announcement for this meeting was
previously published in 81 FR 52713.
FOR FURTHER INFORMATION CONTACT:
Rebecca A. Womeldorf, Rules
Committee Secretary, Rules Committee
SUMMARY:
Support Office, Administrative Office of
the United States Courts, Washington,
DC 20544, telephone (202) 502–1820.
Dated: December 22, 2016.
Rebecca A. Womeldorf,
Rules Committee Secretary.
[FR Doc. 2016–31349 Filed 12–27–16; 8:45 am]
BILLING CODE 2210–55–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: AMRI
Rensselaer, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before February 27, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
September 26, 2016, AMRI Rensselaer,
Inc., 33 Riverside Avenue, Rensselaer,
New York 12144 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
[FR Doc. 2016–31335 Filed 12–27–16; 8:45 am]
[Investigation Nos. 701–TA–249 and 731–
TA–262, 263, and 265 (Fourth Review)]
sradovich on DSK3GMQ082PROD with NOTICES
Background
The Commission, pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)),
instituted these reviews on October 1,
2015 (80 FR 59192) and determined on
January 4, 2016 that it would conduct
full reviews (81 FR 1967, January 14,
2016). Notice of the scheduling of the
Commission’s reviews and of a public
hearing to be held in connection
therewith was given by posting copies
of the notice in the Office of the
Secretary, U.S. International Trade
Commission, Washington, DC, and by
publishing the notice in the Federal
Register on June 23, 2016 (81 FR 40921).
The hearing was held in Washington,
DC, on October 20, 2016, and all
persons who requested the opportunity
were permitted to appear in person or
by counsel.
The Commission made these
determinations pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determinations
in these reviews on December 21, 2016.
The views of the Commission are
contained in USITC Publication 4655
(December 2016), entitled Iron
Construction Castings from Brazil,
Canada, and China: Investigation Nos.
701–TA–249 and 731–TA–262, 263, and
265 (Fourth Review).
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
VerDate Sep<11>2014
18:54 Dec 27, 2016
Jkt 241001
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
95639
E:\FR\FM\28DEN1.SGM
28DEN1
95640
Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices
Controlled substance
Drug code
Codeine ...........................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Morphine ..........................................................................................................................................................................
The company plans to manufacture
bulk controlled substances for use in
product development and for
distribution to its customers.
Dated: December 20, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016–31284 Filed 12–27–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Noramco, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
DATES:
or before January 27, 2017. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
January 27, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and request for hearing on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers
importers, and exporters of, controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on October
14, 2016, Noramco, Inc., 1440 Olympic
Drive, Athens, Georgia 30601 applied to
be registered as an importer of the
following basic classes of controlled
substances:
Drug code
Phenylacetone .................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Poppy Straw Concentrate ...............................................................................................................................................
Tapentadol .......................................................................................................................................................................
sradovich on DSK3GMQ082PROD with NOTICES
[FR Doc. 2016–31281 Filed 12–27–16; 8:45 am]
BILLING CODE 4410–09–P
18:54 Dec 27, 2016
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Navinta LLC
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before February 27, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
Dated: December 19, 2016.
Louis J. Milione,
Assistant Administrator.
VerDate Sep<11>2014
Drug Enforcement Administration
ACTION:
Jkt 241001
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
8501
9333
9670
9780
Schedule
II
II
II
II
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
September 19, 2016, Navinta LLC, 1499
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
II
II
II
II
II
SUPPLEMENTARY INFORMATION:
Controlled substance
The company plans to import
thebaine derivatives (9333) as reference
standards. The company plans to import
an intermediate form of tapentadol
(9780) to bulk manufacture tapentadol
for distribution to its customers. The
company plans to import phenylacetone
(8501) and poppy straw concentrate
(9670) to manufacture other controlled
substances.
9050
9143
9150
9193
9300
Schedule
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 81, Number 249 (Wednesday, December 28, 2016)]
[Notices]
[Pages 95639-95640]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31284]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: AMRI
Rensselaer, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before February 27, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
September 26, 2016, AMRI Rensselaer, Inc., 33 Riverside Avenue,
Rensselaer, New York 12144 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
[[Page 95640]]
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Codeine............................ 9050 II
Oxycodone.......................... 9143 II
Hydromorphone...................... 9150 II
Hydrocodone........................ 9193 II
Morphine........................... 9300 II
------------------------------------------------------------------------
The company plans to manufacture bulk controlled substances for use
in product development and for distribution to its customers.
Dated: December 20, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016-31284 Filed 12-27-16; 8:45 am]
BILLING CODE 4410-09-P
